<DOC>
	<DOCNO>NCT00156182</DOCNO>
	<brief_summary>This study design determine long-term safety asoprisnil 10 mg woman one uterine fibroid initial 12 week study M99-144 .</brief_summary>
	<brief_title>A Long-Term Safety Study Asoprisnil Treatment Uterine Fibroids .</brief_title>
	<detailed_description>No medical therapy currently available long-term treatment uterine fibroid . The objective study determine long-term safety asoprisnil 10 mg daily 6 month , initial 12 week study M99-144 , woman one uterine fibroid , confirm ultrasound study M99-144 . The safety endpoint study base ultrasound endometrial biopsy result , adverse event , change baseline laboratory value vital sign .</detailed_description>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<criteria>Completed dosing Day 84 procedure site study M99144 No interruption dose Otherwise continue good health Any abnormal lab result studydoctor considers significant History severe reaction current use hormone therapy History alcohol drug abuse</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>48 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Fibroid Uterus</keyword>
	<keyword>Leiomyoma</keyword>
	<keyword>Uterine Fibroids</keyword>
	<keyword>asoprisnil</keyword>
</DOC>